autologous γδT cells

BIOLOGICAL2 trials

Conditions

Chronic Lymphoblastic LeukemiaHepatocellular CarcinomaNon-Hodgkin's LymphomaPeripheral T Cell LymphomaRelapsed or Refractory B Cell Non-Hodgkin's Lymphoma

Early Phase 1

γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

NCT04028440

Institute of Hematology & Blood Diseases Hospital, ChinaChronic Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Peripheral T Cell Lymphoma +1

Start: 2019-10-31End: 2022-03-31Target: 6Updated: 2019-09-26

Phase 1

Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells

NCT04032392

Beijing 302 HospitalHepatocellular Carcinoma

Start: 2019-07-23End: 2022-07-30Target: 20Updated: 2019-07-25

autologous γδT cells

Sponsors

Conditions

Early Phase 1

Phase 1